Oncodesign Precision Medicine (XPAR:ALOPM) Earnings per Share (Diluted) : € (TTM As of Jun. 2022)

Oncodesign Precision Medicine Earnings per Share (Diluted) Chart

Competitive Comparison of Oncodesign Precision Medicine's Earnings per Share (Diluted)

For the Biotechnology subindustry, Oncodesign Precision Medicine's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's PE Ratio distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's PE Ratio falls into.

Oncodesign Precision Medicine Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Oncodesign Precision Medicine's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2021 is calculated as

Oncodesign Precision Medicine's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2022 is calculated as

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Oncodesign Precision Medicine  (XPAR:ALOPM) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Oncodesign Precision Medicine Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine (XPAR:ALOPM) Business Description